PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702, USA.\', \'Section on Immuno-Engineering, National Institute for Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20894, USA.\', \'Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702, USA. Electronic address: dom.esposito@nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1046-5928(20)30393-410.1016/j.pep.2020.105802
?:doi
?:hasPublicationType
?:journal
  • Protein expression and purification
is ?:pmid of
?:pmid
?:pmid
  • 33248226
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.648
?:rankingScore_hIndex
  • 76
?:title
  • Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33248226>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33248226>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all